Complete 3 day programme
Wednesday programme Friday programme

Scientific Meeting 2017
Day 1
June 22nd 2017
8:15 AM
Registration at the Exhibition with coffee and pastries
8:50 AM
Welcome, housekeeping and introductions
Hugo Henderson
London
8:55 AM
Session I – Thyroid Eye Disease

A Multidisciplinary Thyroid Eye Disease session with the aim of enabling equitable patient access for TED services on a regional basis
The final format of the session will be democratically determined
by a survey of the membership
Please fill in the 5 minute survey here
Chaired by:

Vickie Lee
London
9:00 AM
Improving access for specialised TED services with TEAMEd
Colin Dayan
Cardiff
9:10 AM
How to share good practice within and between different specialities
Stephen Robinson
London
9:20 AM
Benchmarking Thyroid Eye Disease Services
Rachna Murthy
East Anglia
9:30 AM
Mapping and signposting of Regional Thyroid Eye Services
Vickie Lee
London
9:40 AM
A snapshot of MDT Thyroid Services around the UK

09.40 Miss Faye Mellington (Birmingham),
09.44 Miss Rebecca Ford (Bristol),
09.48 Miss Anjana Haridas (Cardiff),
09.52 Mr Steven White (Belfast),
09.56 Paul Cauchi (Scotland)

10:00 AM
Session II – Free Papers – Thyroid Eye Disease

10.05 am
Unravelling the code of Graves’ Orbitopathy – The importance of serial TSH-Receptor Antibody levels in predicting prognosis and the impact of smoking, Radioiodine and Thyroidectomy 101
Vignesh Paulpandian – (abstract)

10.10 am
Measurement of changes in orbital compliance following orbital decompression surgery: a new quantitative technique 102
Richard Hart – (abstract)

10.15 am
Phenotypes in Thyroid Eye Disease 103
Jimmy Uddin – (abstract)

10.20 am
An Audit of the Use of Radiotherapy in Thyroid Eye Disease (TED) at a Tertiary Referral Centre 104
James Young – (abstract)

10.25 am
A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy 105
Yun Wong – (abstract)

10.30 am
Proposing audit standards for joint thyroid eye disease clinics: a 5 year audit of the patient pathway 106
Sonali Nagendran – (abstract)

10.35 am
Combined IntraVenous methylprednisolone with orbital radiotherapy for the treatment of thyroid eye disease. The Sheffield experience. 107
Konstantinos Kopsidas – (abstract)

10.40 am
Application of 3D imaging system for orbital volume changes after orbital decompression on Thyroid Eye Disease 108
Fabiola Murta – (abstract)

Chaired by:

Rachna Murthy
East Anglia
Priya Bhatt
Bolton
10:45 AM
Tea, Coffee and Posters at the trade exhibition
11:15 AM
Session III – Lacrimal

Chaired by:

Jane Olver
London
Hugo Henderson
London
11:20 AM
Nasolacrimal duct dysfunction in children
Ashok Grover
New Delhi
11:32 AM
The harmony of DCR
Jane Olver
London
11:44 AM
Predictive Factors in TELDR (Transcanalicular Endoscopic Lacrimal Duct Recanalization)
Reynaldo M Javate
Philippines
12:01 PM
Management of Canalicular Obstruction
Yoon-Duck Kim
Republic of Korea
12:13 PM
Discussion
12:30 PM
Session IV – Guest Lecture – Breakthrough Therapy for TED
Raymond Douglas
USA
1:00 PM
Lunch and Posters at the trade exhibition
2:00 PM
Session V – Free Papers – Eyelids and Eyelid Tumours

14.05 pm
UV imaging reveals areas on the face that are prone to skin cancer are disproportionately missed during sunscreen application. 109
Kareem Hassanin – (abstract)

14.10 pm
Evaluating eyelid profile after ptosis repair 110
Christopher Schulz – (abstract)

14.15 pm
Primary mucinous carcinoma of the eyelid 111
John Bladen – (abstract)

14.20 pm
5% Imiquimod for Superficial, Nodular and Mixed Type Basal Cell Carcinoma: 3- Year Results 112
Dimitra Gousia – (abstract)

14.25 pm
The national incidence of squamous cell carcinomas in England over a fifteen year period 113
James Wawrzynski – (abstract)

14.30 pm
Corneal Neurotization: Restoration of Corneal Sensation with Regional Nerve Grafts 114
Raman Malhotra – (abstract)

14.35 pm
Considerations of upper blepharoplasty with respect to skin excision and skin crease position: a prospective study of 150 cases. 115
Paul Rosser – (abstract)

14.40 pm
Peri-Ocular and facial lipofilling 116
Michel Tazartes – (abstract)

Chaired by:

Daniel Morris
Cardiff
Henry Smith
Maidstone
2:45 PM
Session VI – Skin Tumours

Chaired by:

Claire Daniel
London
2:50 PM
Medical management of skin tumours
Vivian Yin
British Columbia
3:10 PM
Management of pigmented conjunctival lesions
Prof Mandeep Sagoo
London
3:30 PM
Panel Discussion – how do you manage difficult skin tumours?
3:45 PM
Tea, Coffee and Posters at the trade exhibition
4:15 PM
Session VII – International

Chaired by:

Naresh Joshi
London
Ben Parkin
Bournemouth
4:16 PM
Understanding the complexity of capacity building: Lessons from Nepal
Vivian Yin
British Columbia
4:30 PM
Facing up to the mammoth challenge of blindness in India
Ashok Grover
New Delhi
4:45 PM
Geopolitics and a Syndicate for Change: St John in the modern world
David Verity
London
5:00 PM
AGM
5:45 PM
Meeting Close
7:30 PM
Gala Dinner at The Dorchester Hotel, London

8:15 AM
Registration at the Exhibition with coffee and pastries
8:50 AM
Welcome, housekeeping and introductions
Hugo Henderson
London
8:55 AM
Session I – Thyroid Eye Disease

A Multidisciplinary Thyroid Eye Disease session with the aim of enabling equitable patient access for TED services on a regional basis
The final format of the session will be democratically determined
by a survey of the membership
Please fill in the 5 minute survey here
Chaired by:

Vickie Lee
London
9:00 AM
Improving access for specialised TED services with TEAMEd
Colin Dayan
Cardiff
9:10 AM
How to share good practice within and between different specialities
Stephen Robinson
London
9:20 AM
Benchmarking Thyroid Eye Disease Services
Rachna Murthy
East Anglia
9:30 AM
Mapping and signposting of Regional Thyroid Eye Services
Vickie Lee
London
9:40 AM
A snapshot of MDT Thyroid Services around the UK

09.40 Miss Faye Mellington (Birmingham),
09.44 Miss Rebecca Ford (Bristol),
09.48 Miss Anjana Haridas (Cardiff),
09.52 Mr Steven White (Belfast),
09.56 Paul Cauchi (Scotland)

10:00 AM
Session II – Free Papers – Thyroid Eye Disease

10.05 am
Unravelling the code of Graves’ Orbitopathy – The importance of serial TSH-Receptor Antibody levels in predicting prognosis and the impact of smoking, Radioiodine and Thyroidectomy 101
Vignesh Paulpandian – (abstract)

10.10 am
Measurement of changes in orbital compliance following orbital decompression surgery: a new quantitative technique 102
Richard Hart – (abstract)

10.15 am
Phenotypes in Thyroid Eye Disease 103
Jimmy Uddin – (abstract)

10.20 am
An Audit of the Use of Radiotherapy in Thyroid Eye Disease (TED) at a Tertiary Referral Centre 104
James Young – (abstract)

10.25 am
A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy 105
Yun Wong – (abstract)

10.30 am
Proposing audit standards for joint thyroid eye disease clinics: a 5 year audit of the patient pathway 106
Sonali Nagendran – (abstract)

10.35 am
Combined IntraVenous methylprednisolone with orbital radiotherapy for the treatment of thyroid eye disease. The Sheffield experience. 107
Konstantinos Kopsidas – (abstract)

10.40 am
Application of 3D imaging system for orbital volume changes after orbital decompression on Thyroid Eye Disease 108
Fabiola Murta – (abstract)

Chaired by:

Rachna Murthy
East Anglia
Priya Bhatt
Bolton
10:45 AM
Tea, Coffee and Posters at the trade exhibition
11:15 AM
Session III – Lacrimal

Chaired by:

Jane Olver
London
Hugo Henderson
London
11:20 AM
Nasolacrimal duct dysfunction in children
Ashok Grover
New Delhi
11:32 AM
The harmony of DCR
Jane Olver
London
11:44 AM
Predictive Factors in TELDR (Transcanalicular Endoscopic Lacrimal Duct Recanalization)
Reynaldo M Javate
Philippines
12:01 PM
Management of Canalicular Obstruction
Yoon-Duck Kim
Republic of Korea
12:13 PM
Discussion
12:30 PM
Session IV – Guest Lecture – Breakthrough Therapy for TED
Raymond Douglas
USA
1:00 PM
Lunch and Posters at the trade exhibition
2:00 PM
Session V – Free Papers – Eyelids and Eyelid Tumours

14.05 pm
UV imaging reveals areas on the face that are prone to skin cancer are disproportionately missed during sunscreen application. 109
Kareem Hassanin – (abstract)

14.10 pm
Evaluating eyelid profile after ptosis repair 110
Christopher Schulz – (abstract)

14.15 pm
Primary mucinous carcinoma of the eyelid 111
John Bladen – (abstract)

14.20 pm
5% Imiquimod for Superficial, Nodular and Mixed Type Basal Cell Carcinoma: 3- Year Results 112
Dimitra Gousia – (abstract)

14.25 pm
The national incidence of squamous cell carcinomas in England over a fifteen year period 113
James Wawrzynski – (abstract)

14.30 pm
Corneal Neurotization: Restoration of Corneal Sensation with Regional Nerve Grafts 114
Raman Malhotra – (abstract)

14.35 pm
Considerations of upper blepharoplasty with respect to skin excision and skin crease position: a prospective study of 150 cases. 115
Paul Rosser – (abstract)

14.40 pm
Peri-Ocular and facial lipofilling 116
Michel Tazartes – (abstract)

Chaired by:

Daniel Morris
Cardiff
Henry Smith
Maidstone
2:45 PM
Session VI – Skin Tumours

Chaired by:

Claire Daniel
London
2:50 PM
Medical management of skin tumours
Vivian Yin
British Columbia
3:10 PM
Management of pigmented conjunctival lesions
Prof Mandeep Sagoo
London
3:30 PM
Panel Discussion – how do you manage difficult skin tumours?
3:45 PM
Tea, Coffee and Posters at the trade exhibition
4:15 PM
Session VII – International

Chaired by:

Naresh Joshi
London
Ben Parkin
Bournemouth
4:16 PM
Understanding the complexity of capacity building: Lessons from Nepal
Vivian Yin
British Columbia
4:30 PM
Facing up to the mammoth challenge of blindness in India
Ashok Grover
New Delhi
4:45 PM
Geopolitics and a Syndicate for Change: St John in the modern world
David Verity
London
5:00 PM
AGM
5:45 PM
Meeting Close
7:30 PM
Gala Dinner at The Dorchester Hotel, London
Select date to see events.